Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Virahep-C: Antiviral Therapy in Chronic Hepatitis C
NCT00038974Phase 3Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Aug 2002
- Primary completion
- Dec 2004
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of peginterferon alfa-2a, ribavirin in hepatitis C virus infection, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Aug 2002; status: completed.
02
Drugs
peginterferon alfa-2aribavirin
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT00038974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00038974.